Neumann-Mangoldt P
Fortschr Med. 1979 Dec 1;97(45):(2117-9).
The efficacy of Essaven-capsules in venous circulatory disorders of the leg was assessed under the conditions of everyday general practice in a double blind trial including 34 out-patients. During the 4 week-treatment Essaven proved to be significantly superior to a placebo of identical appearance as regards the parameter pain in the legs, skin lesions, circumference of the ankle, and diuretic performance. The dosage was 3 X 2 capsules per day.
在日常普通医疗实践条件下，采用双盲试验对34名门诊患者评估了Essaven胶囊治疗腿部静脉循环障碍的疗效。在为期4周的治疗期间，就腿部疼痛、皮肤损伤、脚踝周长和利尿性能等参数而言，Essaven被证明明显优于外观相同的安慰剂。剂量为每日3次，每次2粒胶囊。
